Senior Director, Medical Excellence

Full Time On-Site/Hybrid Medical Affairs Director Medical Excellence Apply for this Job The Senior Director, Medical Excellence, is a key member of the Global Medical Affairs (GMA) Leadership team who will lead a cross functional team to implement key processes and programs ensuring consistency and high quality across the Medical Organization. The successful candidate will foster a culture of medical excellence and will drive continued strategic alignment and execution throughout the Medical Affairs organization. This role will oversee a team of Medical Affairs leaders representing Operations, Medical Information, Medical Training, Early Access Programs, and Compassionate Use.

Key Responsibilities Include:

• Key member of the Medical Affairs Leadership Team
• Lead a cross functional Medical Affairs team comprised of Medical Training, Medical Information, Medical Operations, and Early Access Programs.
• Responsible for fostering medical excellence through the GMA organization in collaboration with Medical Affairs Leadership Team
• Collaborate with Medical Directors, Field Medical, Advocacy, and Regional/Local Medical Affairs teams to ensure high quality programs are developed and delivered across medical information, training, operations, and early access programs
• Identify efficiencies and opportunities across therapeutic areas, managing resources accordingly
• Partner with Clinical and Commercial Excellence to enable high performing organization
• Monitor the landscape and deliver ongoing assessments of strategy and initiatives to identify gaps and opportunities offering strategic advantage
• Responsible for line management, professional development, and mentorship of direct report(s) including providing feedback on employee performance and goal setting
• Responsible for driving strategic initiatives for employee development, process, and business improvements
• Fosters and reinforces a culture that aligns with the Apellis Values
• Up to 40% domestic and/or international travel
• Other duties and responsibilities as required

Education, Registration & Certification:

• Must have a PhD, Pharm D or MD level degree or equivalent

Experience:

• 12-15+ years of experience in a Medical Affairs organization
• 5-10+ years of experience leading cross functional teams
• Exhibits strong global mindset
• Pharmaceutical/Biotech launch experience preferred

Skills, Knowledge & Abilities:

• Proven ability to lead in a fast-paced environment, enabling the team to prioritize and manage multiple competing tasks and demands while ensuring overall quality and integrity
• Enables creative problem solving, encourages unique solutions, and solves difficult problems with effective solutions
• Creates an environment that enables open, available, and transparent communication
• Strong interpersonal skill set necessary to influence and maintain internal effective and external collaborator relationships
• Facilitates productive dialogue that empowers others to share input/recommendations/perspective, while driving the group to make a decision or take a position.
• Highly developed written and verbal communication skills, including ability to effectively articulate highly technical/complex concepts to audiences with differing levels of experience
• Demonstrated ability to effectively lead, influence, and manage within a matrixed organization
• Exceptional leadership skills and ability to inspire, motivate and mentor teams

Benefits and Perks:

Apellis offers a great benefit package which includes: health insurance with full premium coverage, 401K with company match, paid time off (PTO), long- term disability insurance, life insurance and more! Visit https://apellis.com/careers/ to learn more.

Company Background:

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.